These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15267227)

  • 1. Phosphorylcholine-carbohydrate-protein conjugates efficiently induce hapten-specific antibodies which recognize both Streptococcus pneumoniae and Neisseria meningitidis: a potential multitarget vaccine against respiratory infections.
    Bay S; Huteau V; Zarantonelli ML; Pires R; Ughetto-Monfrin J; Taha MK; England P; Lafaye P
    J Med Chem; 2004 Jul; 47(16):3916-9. PubMed ID: 15267227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity of human immunoglobulin G2 recognizing phosphorylcholine and evidence for protection against major bacterial pathogens of the human respiratory tract.
    Goldenberg HB; McCool TL; Weiser JN
    J Infect Dis; 2004 Oct; 190(7):1254-63. PubMed ID: 15346335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiotope vaccine against Streptococcus pneumoniae. A precursor study.
    Ward MM; Ward RE; Huang JH; Kohler H
    J Immunol; 1987 Oct; 139(8):2775-80. PubMed ID: 3498770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Report of the 3d International Conference on the immunology of meningococcal meningitis. Current status of meningococcus B vaccine].
    Del Real G
    Rev Sanid Hig Publica (Madr); 1979; 53(11-12):1639-49. PubMed ID: 45419
    [No Abstract]   [Full Text] [Related]  

  • 6. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns.
    Mogensen TH; Paludan SR; Kilian M; Ostergaard L
    J Leukoc Biol; 2006 Aug; 80(2):267-77. PubMed ID: 16731773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphorylcholine epitope undergoes phase variation on a 43-kilodalton protein in Pseudomonas aeruginosa and on pili of Neisseria meningitidis and Neisseria gonorrhoeae.
    Weiser JN; Goldberg JB; Pan N; Wilson L; Virji M
    Infect Immun; 1998 Sep; 66(9):4263-7. PubMed ID: 9712776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of new pediatric vaccines: progress and challenges].
    Siegrist CA
    Rev Med Suisse Romande; 1998 Apr; 118(4):395-401. PubMed ID: 9623292
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucosal vaccination against bacterial respiratory infections.
    Baumann U
    Expert Rev Vaccines; 2008 Oct; 7(8):1257-76. PubMed ID: 18844598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A semi-synthetic glycoconjugate antigen prepared by chemical glycosilation of pertussis toxin by a meningococcal group C oligosaccharide hapten.
    Porro M; Costantino P; Fabbiani S; Pellegrini V; Viti S
    Dev Biol Stand; 1985; 61():525-30. PubMed ID: 2423402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of immune response to Streptococcus pneumoniae by administration of oral viridans streptococci via phosphorylcholine determinant.
    Miwa Y; Ito HO; Inoue M; Oho T
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):441-8. PubMed ID: 15708320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Emphasis on bacterial vaccines].
    Huet M
    Arch Inst Pasteur Tunis; 1982 Dec; 59(4):481-93. PubMed ID: 6820928
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB; Carter AT; Hitchin E; Wells JM
    J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
    Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
    Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of conjugate vaccines for Africa.
    Kieny MP; LaForce FM
    Vaccine; 2007 Sep; 25 Suppl 1():A108-10. PubMed ID: 17548136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays.
    Skovsted IC; Kerrn MB; Sonne-Hansen J; Sauer LE; Nielsen AK; Konradsen HB; Petersen BO; Nyberg NT; Duus JØ
    Vaccine; 2007 Aug; 25(35):6490-500. PubMed ID: 17655983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate recognition of a structure motif for phosphorylcholine post-translational modification in Neisseria meningitidis.
    Jen FE; Jones CE; Wilson JC; Schulz BL; Jennings MP
    Biochem Biophys Res Commun; 2013 Feb; 431(4):808-14. PubMed ID: 23274496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis.
    Zhu D; Barniak V; Zhang Y; Green B; Zlotnick G
    Vaccine; 2006 Jun; 24(26):5420-5. PubMed ID: 16621173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.